X
Email:
sales@ruixibiotech.com

PDMA modified NaYF4:Yb,Er@NaYF4:Nd core-shell upconversion Nanoparticles,808 nm excitation

Poly(N,N-dimethylacrylamide)-coated upconverting NaYF4:Yb,Er@NaYF4:Nd core–shell nanoparticles,808 nm excitation,Water Soluble

Catalog # Pkg Size Price(USD) Quantity Buy this product
R-M2-9658 5ml 1009.00
- +
+ Add to cart
R-M2-9658 10ml 1699.00
- +
+ Add to cart

Product description

The PDMA-modified UCNPs/Poly(N,N-dimethylacrylamide)-coated upconverting NaYF4:Yb,Er@NaYF4:Nd core–shell nanoparticles,808 nm excitation,Water Soluble can be used for in vivo and ex vivo imaging due to their low toxicity and high signal intensity.The nanoparticles can be utilized in photodynamic therapy (PDT) or photothermal therapy (PTT) for cancer treatment, where the upconversion emission can activate photosensitizers or induce thermal effects.The functionalization potential of PDMA allows for targeted drug delivery applications, where drugs can be conjugated to the PDMA layer for controlled release.

PDMA modified NaYF4:Yb,Er@NaYF4:Nd core-shell upconversion Nanoparticles,808 nm excitation

Appearance Liquid, suspension
Concentration 1mg/ml
Solubility Water
Excitation wavelength 808 nm
Storage 4℃, protected from light and moisture
Transportation 4-25℃ temperature for up to 3 weeks
Stability 6 months
Document

Related Product